Pentazocine is a DEA Schedule IV controlled substance. Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III. It is a Other substances substance. It is grouped under the following drug class(es): Controlled drug substances and Schedule IV controlled substances. Its therapeutic use is listed as analgesics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Fortalin and Pentagin. It is listed as a controlled drug substance (Schedule IV). Its PubChem CID is 441278.
Pentazocine
| CAS No | 359-83-1 |
|---|---|
| Molecular Formula | C19H27NO |
| Molecular Weight | 285.4 g/mol |
| Synonyms | (1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pentazocine is a DEA Schedule IV controlled substance. Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III. It is a Other substances substance.
The listed CAS number is 359-83-1.
The listed molecular formula is C19H27NO.
The listed molecular weight is 285.4 g/mol.
(1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol.
The source lists Fortalin and Pentagin.